Fastidious intracellular bacteria as causal agents of community-acquired pneumonia (Q37768416)

22 August 2017

1 reference

title

Fastidious intracellular bacteria as causal agents of community-acquired pneumonia (English)

1 reference

22 August 2017

0 references

Frédéric Lamoth

1

0 references

Gilbert Greub

object named as

Gilbert Greub

series ordinal

2

0 references

publication date

1 July 2010

1 reference

Expert Review of Anti-infective Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

8

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

775-790

1 reference

BTS Guidelines for the Management of Community Acquired Pneumonia in Adults

22 August 2017

cites work

1 reference

British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood

21 January 2018

1 reference

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

Quality of Care, Process, and Outcomes in Elderly Patients With Pneumonia

21 January 2018

1 reference

The atypical pneumonias: clinical diagnosis and importance

21 January 2018

1 reference

Atypical pneumonia--time to breathe new life into a useful term?

21 January 2018

1 reference

A worldwide perspective of atypical pathogens in community-acquired pneumonia.

21 January 2018

1 reference

Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy

21 January 2018

1 reference

Community-acquired pneumonia. A prospective outpatient study

21 January 2018

1 reference

Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections.

21 January 2018

1 reference

Infection due to Legionella species other than L. pneumophila

21 January 2018

1 reference

Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey

21 January 2018

1 reference

Amoebal pathogens as emerging causal agents of pneumonia

21 January 2018

1 reference

Legionnaires' disease: description of an epidemic of pneumonia

21 January 2018

1 reference

Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease

21 January 2018

1 reference

Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae

21 January 2018

1 reference

Isolation of Legionella pneumophila from clinical specimens via amoebae, and the interaction of those and other isolates with amoebae

21 January 2018

1 reference

Legionella drozanskii sp. nov., Legionella rowbothamii sp. nov. and Legionella fallonii sp. nov.: three unusual new Legionella species

21 January 2018

1 reference

Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis

21 January 2018

1 reference

Epidemiology of severe pneumonia caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-year, population-based surveillance for severe pneumonia in Thailand

21 January 2018

1 reference

Legionella-like amebal pathogens--phylogenetic status and possible role in respiratory disease

21 January 2018

1 reference

Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system.

21 January 2018

1 reference

Systematic review and metaanalysis: urinary antigen tests for Legionellosis.

21 January 2018

1 reference

Legionella spp. and Legionnaires' disease

21 January 2018

1 reference

Legionella and Legionnaires' disease: 25 years of investigation

21 January 2018

1 reference

The impact of diagnosis by legionella urinary antigen test on the epidemiology and outcomes of Legionnaires' disease

21 January 2018

1 reference

Detection of Legionella pneumophila Serogroup 1 Antigen in Bronchoalveolar Lavage Fluid by an Immunochromatographic Assay

21 January 2018

1 reference

Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease

21 January 2018

1 reference

Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group

21 January 2018

1 reference

Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen

21 January 2018

1 reference

Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease

21 January 2018

1 reference

Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes

21 January 2018

1 reference

Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin

21 January 2018

1 reference

Activities of newer quinolones against Legionella group organisms

21 January 2018

1 reference

Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes

21 January 2018

1 reference

The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes

21 January 2018

1 reference

Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila

21 January 2018

1 reference

Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents.

21 January 2018

1 reference

Legionella: macrolides or quinolones?

21 January 2018

1 reference

Comparative Activity of Ciprofloxacin, Ofloxacin, Levofloxacin, and Erythromycin Against Legionella Species by Broth Microdilution and Intracellular Susceptibility Testing in HL-60 Cells

21 January 2018

1 reference

Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing

21 January 2018

1 reference

In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia

21 January 2018

1 reference

Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides

21 January 2018

1 reference

Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy

21 January 2018

1 reference

Fluoroquinolones vs macrolides in the treatment of Legionnaires disease.

21 January 2018

1 reference

Levofloxacin efficacy in the treatment of community-acquired legionellosis

21 January 2018

1 reference

The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.

21 January 2018

1 reference

STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA : A FILTERABLE AGENT TRANSMISSIBLE TO COTTON RATS, HAMSTERS, AND CHICK EMBRYOS.

21 January 2018

1 reference

Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections

21 January 2018

1 reference

Mycoplasma pneumoniae and its role as a human pathogen

21 January 2018

1 reference

Intracellular DNA replication and long-term survival of pathogenic mycoplasmas

21 January 2018

1 reference

Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity

21 January 2018

1 reference

Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care

21 January 2018

1 reference

Outbreak of acute respiratory disease caused by Mycoplasma pneumoniae on board a deployed U.S. navy ship

21 January 2018

1 reference

Community outbreak of Mycoplasma pneumoniae infection: school-based cluster of neurologic disease associated with household transmission of respiratory illness

21 January 2018

1 reference

Mycoplasma pneumoniae as a cause of pneumonia, lung abscess and pleural effusion: a case report

21 January 2018

1 reference

Disseminated pyogenic Mycoplasma pneumoniae infection in a renal transplant recipient, detected by broad-range polymerase chain reaction

21 January 2018

1 reference

Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimicrobial susceptibility of the isolates

21 January 2018

1 reference

Comparison of four Mycoplasma pneumoniae IgM-, IgG- and IgA-specific enzyme immunoassays in blood donors and patients

21 January 2018

1 reference

Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumonia

21 January 2018

1 reference

Real-time detection of Mycoplasma pneumoniae in respiratory samples with an internal processing control

21 January 2018

1 reference

Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae

21 January 2018

1 reference

Sample type is crucial to the diagnosis of Mycoplasma pneumoniae pneumonia by PCR.

21 January 2018

1 reference

Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmen

21 January 2018

1 reference

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children

21 January 2018

1 reference

Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.

21 January 2018

1 reference

Etiology and treatment of community-acquired pneumonia in ambulatory children

21 January 2018

1 reference

Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia

21 January 2018

1 reference

Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study

21 January 2018

1 reference

Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics

21 January 2018

1 reference

Resistance of Mycoplasma pneumoniae to macrolides, lincomycin and streptogramin B.

21 January 2018

1 reference

Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan

21 January 2018

1 reference

Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation

21 January 2018

1 reference

Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia

21 January 2018

1 reference

Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae

21 January 2018

1 reference

First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years.

21 January 2018

1 reference

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe

21 January 2018

1 reference

Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis

21 January 2018

1 reference

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin

21 January 2018

1 reference

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study

21 January 2018

1 reference

Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group

21 January 2018

1 reference

In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively

21 January 2018

1 reference

Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia

21 January 2018

1 reference

Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults

21 January 2018

1 reference

Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia

21 January 2018

1 reference

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections

21 January 2018

1 reference

Chlamydia pneumoniae sp. nov. for Chlamydia sp. Strain TWAR

21 January 2018

1 reference

21 January 2018

Chlamydophila pneumoniae

1 reference

Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods

21 January 2018

1 reference

Chlamydia species as a cause of community-acquired pneumonia in Canada

21 January 2018

1 reference

Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus.

21 January 2018

1 reference

Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000.

21 January 2018

1 reference

Severe community-acquired pneumonia with acute hypoxemic respiratory failure due to primary infection with Chlamydia pneumoniae in a previously healthy adult

21 January 2018

1 reference

Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia

21 January 2018

1 reference

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

21 January 2018

1 reference

Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group

21 January 2018

1 reference

Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae

21 January 2018

1 reference

Advances in the management of Chlamydia pneumoniae infections

21 January 2018

1 reference

Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia

21 January 2018

1 reference

Chlamydophila psittaci infections in birds: a review with emphasis on zoonotic consequences

21 January 2018

1 reference

Chlamydophila psittaci infections in humans during an outbreak of psittacosis from poultry in Germany.

21 January 2018

1 reference

Evaluation of a Chlamydophila psittaci infection diagnostic platform for zoonotic risk assessment

21 January 2018

1 reference

Cross-reaction between the genus-specific lipopolysaccharide antigen of Chlamydia spp. and the lipopolysaccharides of Porphyromonas gingivalis, Escherichia coli O119 and Salmonella newington: implications for diagnosis

21 January 2018

1 reference

Use of a nested PCR-enzyme immunoassay with an internal control to detect Chlamydophila psittaci in turkeys

21 January 2018

1 reference

Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp.

21 January 2018

1 reference

Parachlamydia acanthamoebae, an emerging agent of pneumonia

21 January 2018

1 reference

Pathogenic potential of novel Chlamydiae and diagnostic approaches to infections due to these obligate intracellular bacteria

21 January 2018

1 reference

Parachlamydia acanthamoebae enters and multiplies within human macrophages and induces their apoptosis [corrected].

21 January 2018

1 reference

Intracellular trafficking of Parachlamydia acanthamoebae

21 January 2018

1 reference

The role of monocyte/macrophages as vehicles of dissemination of Simkania negevensis: an in vitro simulation model

21 January 2018

1 reference

Murine model of pneumonia caused by Parachlamydia acanthamoebae

21 January 2018

1 reference

Seroprevalence of IgG antibodies to the chlamydia-like microorganism 'Simkania Z' by ELISA.

21 January 2018

1 reference

High Rate of Simkania negevensis among Canadian Inuit Infants Hospitalized with Lower Respiratory Tract Infections

21 January 2018

1 reference

Infection with Simkania negevensis in Brooklyn, New York

21 January 2018

1 reference

Simkania negevensis in community-acquired pneumonia in Italian children.

21 January 2018

1 reference

Simkania negevensis may be a true cause of community acquired pneumonia in children

21 January 2018

1 reference

Simkania negevensis infection among Brazilian children hospitalized with community-acquired pneumonia.

21 January 2018

1 reference

New diagnostic real-time PCR for specific detection of Parachlamydia acanthamoebae DNA in clinical samples

21 January 2018

1 reference

Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia

21 January 2018

1 reference

Protochlamydia naegleriophila as etiologic agent of pneumonia

21 January 2018

1 reference

Chlamydia-like bacteria in respiratory samples of community-acquired pneumonia patients

21 January 2018

1 reference

Infections with the chlamydia-like microorganism Simkania negevensis, a possible emerging pathogen

21 January 2018

1 reference

Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinoline resistance-determining region of the DNA gyrase A- and topoisomerase-encoding genes

21 January 2018

1 reference

Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae

21 January 2018

1 reference

Q fever in Great Britain; clinical account of eight cases

21 January 2018

1 reference

Concomitant or consecutive infection with Coxiella burnetii and tickborne diseases

21 January 2018

1 reference

Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases

21 January 2018

1 reference

An important outbreak of human Q fever in a Swiss Alpine valley.

21 January 2018

1 reference

Coxiella burnetii pneumonia

21 January 2018

1 reference

Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever

21 January 2018

1 reference

Acute Q fever pneumonia: a review of 80 hospitalized patients

21 January 2018

1 reference

Erythromycin and the treatment of Coxiella burnetii pneumonia

21 January 2018

1 reference

Antibiotic treatment in pneumonia due to Q fever

21 January 2018

1 reference

Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions

21 January 2018

1 reference

Safety profile of quinolone antibiotics in the pediatric population

21 January 2018

1 reference

Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia

21 January 2018

1 reference

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

Chlamydial infections in duck farms associated with human cases of psittacosis in France

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.10.52

1 reference

22 August 2017

1 reference